Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel.
Hydrotropic polymers (HPs) and their micelles have been recently developed as vehicles for delivery of poorly water-soluble drugs, such as paclitaxel (PTX), by oral administration. The release of PTX from HP micelles, however, was slow and it took more than a day for complete release of the loaded PTX. Since the gastrointestinal (GI) transit time is known to be only several hours, pH-sensitive HP micelles were prepared for fast release of the loaded PTX responding to pH changes along the GI tract. Acrylic acid (AA) was introduced, as a release modulator, into HPs by copolymerization with 4-(2-vinylbenzyloxy)-N,N-(diethylnicotinamide) (VBODENA). The AA content was varied from 0% to 50% (in the molar ratio to VBODENA). HPs spontaneously produced micelles in water, and their critical micelle concentrations (CMCs) ranged from 31 microg/mL to 86 microg/mL. Fluorescence probe study using pyrene showed that blank HP micelles possessed a good pH sensitivity, which was clearly observed at relatively high AA contents and pH>6. The pH sensitivity also affected the PTX loading property. Above pH 5, the PTX loading content and loading efficiency in HP micelles were significantly reduced. Although this may be primarily due to the AA moieties, other factors may include PTX degradation and polymer aggregation. The PTX release from HP micelles with more than 20% (mol) AA contents was completed within 12 h in a simulated intestinal fluid (SIF, pH=6.5). The HP micelles without any AA moiety showed very slow release profiles. In the simulated gastric fluid (SGF, pH=1.6), severe degradation of the released PTX was observed. The pH-dependent release of PTX from HP micelles can be used to increase the bioavailability of PTX upon oral delivery.
Kim
Sungwon
S
Departments of Pharmaceutics and Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Kim
Ji Young
JY
Huh
Kang Moo
KM
Acharya
Ghanashyam
G
Park
Kinam
K
D000179:Acrylates / Q000138:chemical synthesis*; D000284:Administration, Oral; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004339:Drug Compounding; D004355:Drug Stability; D005750:Gastric Juice / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D007419:Intestinal Secretions / Q000737:chemistry; D007700:Kinetics; D008823:Micelles; D009536:Niacinamide / Q000031:analogs & derivatives / Q000138:chemical synthesis*; D017239:Paclitaxel / Q000008:administration & dosage / Q000737:chemistry*; D011136:Polysorbates / Q000737:chemistry; D012980:Sodium Salicylate / Q000737:chemistry; D012995:Solubility
D000179:Acrylates; D000972:Antineoplastic Agents, Phytogenic; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D008823:Micelles; D011136:Polysorbates; D009536:Niacinamide; C036658:acrylic acid; D017239:Paclitaxel; D012980:Sodium Salicylate